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Abstract
Preterm birth (defined as birth prior to 37 completed weeks of gestation), occurs in approximately 10% of all births
and is one of the leading causes of neonatal morbidity and mortality worldwide. Preterm infants are born at a time
when kidney development is still ongoing, and consequently can lead to renal impairment (in both the short-term and
long-term), as well as severe glomerular abnormalities in some preterm infants. Since the glomerular abnormalities
are not present in all preterm kidneys, this suggests that it is not preterm birth per se that leads to the glomerular
abnormalities but may relate to factors associated with the etiology of the premature delivery, or factors in neonatal
care. In this review, we provide an overview of what is currently known of how prenatal and postnatal factors can
potentially impact on the immature kidneys of infants born preterm.
Keywords: Preterm birth; Intrauterine growth restriction; Kidney;
Nephrogenesis; Neonatal care
Introduction
Preterm birth occurs in approximately 10% of all births and is one
of the leading causes of neonatal morbidity and mortality worldwide.
Preterm infants are born at a time when their organ systems are
immature and hence, being born early can lead to adverse effects on
organ structure and function both in the short-term and in the long-
term. Preterm birth can lead to renal impairment in the neonatal
period and can lead to glomerular abnormalities in some preterm
infants. Since the glomerular abnormalities are not present in all
preterm kidneys, this suggests that it is not preterm birth per se that
leads to the glomerular abnormalities but may relate to factors
associated with the etiology of the premature delivery or factors in
neonatal care. Indeed, the etiology of preterm birth is multifactorial
and the neonatal care of preterm infants is different for all individuals,
depending on their postnatal sequelae. In this review, we provide an
overview of what is currently known of how prenatal and postnatal
factors can potentially impact on the immature kidneys of infants born
preterm.
Preterm Birth
Preterm birth occurs in approximately 10% of all births and is one
of the leading causes of neonatal morbidity and mortality worldwide
[1]. Preterm birth is defined as birth prior to 37 completed weeks of
gestation, with birth between 38-42 weeks of gestation considered as
full term [2]. Preterm birth can be further sub-classified into
moderately preterm, very preterm and extremely preterm. Moderately
preterm infants are classified as those born between 32 to 36 weeks of
gestation, very preterm births are those born between 28 and 31 weeks
gestation, extremely preterm births are those born before28 weeks
gestation [3]. Babies born prior to 23 weeks usually do not survive.
The majority (60-70%) of preterm newborns are born between 34 and
36 weeks of gestation. The incidence of preterm infants born at 32-33
weeks gestation is ~20% and ~15% are born at 28-31 weeks, preterm
birth prior to 28 weeks is the least common [3].
The global number of preterm deliveries each year has been slowly
increasing and at the present time it is around 10% of births worldwide
[4]. In the USA the incidence of preterm birth is 12.3% [5], in Europe
it is 5-7% [4], and in Australia it is 8.2% [6]. However, within these
populations some ethnic groups have a higher incidence of preterm
birth. For example in African Americans the incidence of preterm
birth is high at 17.5% [7] and in Indigenous Australians 13.3% of all
births are preterm [6]. Of concern, the prevalence of preterm birth in
developing countries is very high; for example, up to 17.5% of the
reported birth sin South Africa are preterm and this is likely to be even
higher as many births are not recorded [4].
Survival following preterm birth (especially in those born very,
extremely preterm) has improved dramatically since the first
introduction of neonatal intensive care units (in the 1960s). With
subsequent refinements in prenatal and neonatal care, newborns born
as early as 25 weeks gestation now have a 80% chance of survival [8,9].
In particular, the use of antenatal/neonatal corticosteroids (which
accelerate lung maturation in the newborn) and surfactant therapy
(which reduces alveolar surface tension in the presence of respiratory
distress syndrome) have facilitated the recent improvement in survival
[10].
The cause of premature delivery is multifactorial and differs with
each pregnancy. It can occur spontaneously or be the result of
emergency induced delivery. The most common identified causes of
spontaneous preterm delivery are onset of premature labour (45%),
and premature pre-labour rupture of the membranes (25%) [3]. The
main identified cause of emergency induced delivery is maternal and
fetal infection (35%) [3]. To date, the etiological mechanisms leading
to spontaneous preterm labour and premature pre-labour rupture of
the membranes are not well defined. There are a number of risk
factors associated with increased risk of preterm delivery [3].
Pregnancy complications that often lead to emergency induced
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preterm delivery include: Chorioamnionitis, placental insufficiency/
abruption, pre-eclampsia, oligohydramnios (abnormal amniotic fluid
levels) and intrauterine growth restriction (IUGR); IUGR is often a co-
morbidity of these other pregnancy complications.
Although there has been a marked improvement in the survival of
preterm infants over recent decades, preterm birth still remains the
leading cause of infant mortality and morbidity. Perinatal mortality is
currently around 6 to 8.5 times higher in preterm infants than in term
infants [11]. Preterm infants are vulnerable to many postnatal
complications due to the increased functional demands in the extra-
uterine environment, at a time when the immature organs are ill-
equipped for the functional transition to life ex-utero.
The increasing awareness of the potential adverse effects of being
born early to immature organ systems has led to many studies over
recent years looking at the consequences of preterm birth on fetal
organ development, such as in the lungs [12], brain [13,14],
gastrointestinal tract [15], and the kidney [16-19]. The effects of
preterm birth in the neonatal kidney form the focus of this review.
Preterm Birth and its Effects on Renal Function and
Nephrogenesis
Renal function
In the case of preterm infants, they are delivered at a time when 
nephrogenesis is often ongoing. In preterm neonates glomerular 
filtration rate (GFR) is very low at birth, and does not rise as rapidly as 
full term infants during the neonatal period [20,21]. As expected, 
glomerular filtration rate has shown to increase more rapidly after 34 
weeks gestation [22,23] which coincides with the timing of the 
completion of nephrogenesis. Numerous studies have shown that 
preterm birth can lead to a high incidence of renal dysfunction in the 
neonate and under severe circumstances this can lead to renal failure 
[24,25]. The incidence of renal impairment in preterm infants is 
difficult to clearly define given that the kidneys are very immature at 
the time of birth. Hence, renal function is quite different in the 
preterm infant when compared to the term infant and many of these 
differences are due to immaturity rather than an underlying 
impairment. Certainly, both glomerular and tubular function are 
influenced by gestational age at birth and hence, it is difficult to 
establish whether the differences in renal function in preterm infants 
compared to term infants are solely due to underdevelopment of the 
nephrons or the result of injury in an immature kidney. During the 
first week after birth, glomerular filtration rate (GFR) is significantly 
lower in preterm infants compared to term infants [26-28] and it is 
positively correlated with gestational age at birth and postnatal age 
[29-31]. Likewise, creatinine clearance, one of the most commonly 
used markers of renal function, is positively correlated with both 
gestational age and postnatal age [20,21,29-39]. In addition, preterm 
neonates excrete high amounts of sodium in the early neonatal period 
compared to term neonates, with the fractional excretion of sodium 
inversely correlated with gestational age and postnatal age [29,39-43].
The presence of high levels of protein in the urine is indicative of
pathological proteinuria (urine total protein ≥ 500 mg/l) and can be
glomerular and/or tubular in origin. Specifically, the presence of
proteins with a high molecular weight (albumin) in the urine, is
indicative of a disruption in the integrity of the glomerular filtration
barrier [44]. Alternatively, high levels of low molecular weight proteins
(such as β2-microglobulin) are indicative of reduced reuptake by the
proximal tubule cells [45,46]. The occurrence of proteinuria in
neonates is strongly linked to gestational age at birth with studies in
preterm infants reporting significantly greater albumin and β2-
microglobulin concentrations over the first month of life in infants
born <32 weeks gestation, compared to neonates born >32 weeks
gestation [39,47]. To date, it remains unclear whether the observed
proteinuria in preterm infants is a result of their renal immaturity or
due to postnatal renal injury.
Acute kidney injury (previously defined as acute renal failure) is
reported to occur in 8% to 24% of preterm infants admitted to
neonatal intensive care units [24,48]. The mortality amongst these
infants that are born <32 weeks gestation has been reported to be as
high as 30-60% [49]. Acute kidney injury is defined as a sustained
extreme decline in creatinine clearance; the initial clinical symptoms
are a marked increase in serum creatinine and/or a sustained very low
urine output [50,51]. The major risk factors for acute kidney injury are
very low gestational age and low birth weight [52]. Other factors that
have been linked to acute kidney injury are: hypotention, hypoxia,
sepsis, maternal and neonatal drug administration (NSAIDs,
indomethacin, antibiotics and vasopressor), a low apgar score,
intraventricular haemorrhage (grade III and IV), necrotising
enterocolitis, patent ductus arteriosus, respiratory distress syndrome,
clinical interventions (intubation at birth),catheterization,
phototherapy, and mechanical ventilation [24,52,53]. Of concern,
mortality rates were reported to be significantly higher in neonates
with renal dysfunction/renal failure [52].
In addition, to the short-term effects in the kidney, preterm birth is
reported to influence long-term renal function [54-56]. For example,
Rodriguez et al. [57], found GFR to be significantly lower in children
ranging in age between 6.1 and 12.4 years who were born preterm,
with evidence of renal injury (defects in tubular transport of
phosphate) [57]. Iacobelli et al. [56], found that microalbuminaria was
present in 8.3% of children examined that were born premature,
ranging from 6-8 years of age. Similar findings were reported in a
study of young adults; a lower GFR, higher serum creatinine and
microalbuminaria was reported at 19 years of age in subjects born at
<32 weeks gestation (and also small for gestational age) [54].
Furthermore, there is strong epidemiological evidence to link
premature birth with the development of hypertension [58-63] and
increased cardiovascular risk during adulthood [64,65]. This ‘risk’ may
be further exacerbated in the presence of impaired renal function,
possibly leading to hypertension, and the possible development of
cardiovascular disease in later life [66].
Nephrogenesis
The nephrons are the functional units of the kidney and
importantly, nephrogenesis (the formation of nephrons) is usually not
completed until late in gestation (approximately 32 to 36 weeks
gestation) [67]. Hence, the majority of preterm infants are born at a
time when nephrogenesis is still ongoing. Over the past decade there
have been a number of studies looking at the effect of preterm birth on
nephrogenesis in the kidney. In the first of these studies, Rodriguez et
al. [16] reported a reduced number of glomerular generations (thus
implying reduced nephron endowment) in autopsied kidneys from
babies that were born preterm compared to those born at term.
However, in that study many of the preterm infants were also IUGR;
hence, in that study interpretation of the findings is difficult, because it
is well known that IUGR leads to reduced nephron endowment (see
later section). Likewise, in another autopsy study the number of
Citation: Ryan D, Black MJ (2015) Preterm Birth and/or Factors that Lead to Preterm Delivery: Effects on the Neonatal Kidney. J Neonatal Biol 4:
168. doi:10.4172/2167-0897.1000168
Page 2 of 12
J Neonatal Biol
ISSN:2167-0897 JNB, an open access journal
Volume 4 • Issue 1 • 1000168
94
glomerular generations was significantly reduced in preterm kidneys
compared to terms [68]. Concomitant with these studies, we have also
conducted a number of studies looking at the effect of premature birth
in immature preterm kidneys, both in a non-human primate model of
preterm birth and in autopsied kidneys of preterm infants. Our studies
have convincingly shown that when nephrogenesis is ongoing in
preterm infants at the time of birth, that nephrogenesis continues after
birth; new nephrons are formed in the extra-uterine environment
[17,19]. In our baboon studies, where the timing of nephrogenesis is
similar to the human, we have shown that the kidneys are significantly
larger in the preterm neonates, with a concomitant decrease in
glomerular density, but nephron number was in the normal range
(thus implying changes in tubular growth) [17]. Of concern, however,
there was a high proportion of abnormal glomeruli (up to 18% in some
kidneys) in the outer renal cortex in some of the preterm neonates.
The abnormal glomeruli exhibited a shrunken immature glomerulus
and an enlarged cystic Bowman’s space. Similarly, in studies
conducted in autopsied kidneys from infants born preterm [19], there
was also an increase in kidney weight relative to body weight (probably
due to the increased postnatal functional demands) and importantly
new glomerular generations were formed after birth. However, there
was a reduced nephrogenic zone width and a reduction in the
proportion of glomeruli in the most immature stages (vesicle, comma-
shaped, S-shaped and capillary loop stages), when compared to
gestational age-matched controls, suggesting that cessation of
nephrogenesis may be accelerated, and nephrogenic potential
adversely impacted upon. To date, there have been no studies that
have looked at exactly when nephrogenesis ceases in the preterm
infant relative to gestational age-matched infants.
Alarmingly, as seen in the preterm baboon kidneys, there was a
high proportion of abnormal glomeruli (with shrunken glomerular
tufts and an enlarged cystic Bowman’s space) in the outer renal cortex
(up to 13% of glomeruli) in some of the preterm human kidneys [19].
A representative example of an abnormal glomerulus in the preterm
human kidney is shown in Figure 1. Given the severity of these
glomerular abnormalities it is unlikely that these glomeruli will ever be
functional. Hence, our findings suggest that in these preterm infants
the endowment of functional nephrons is adversely impacted upon by
preterm birth, thereby affecting renal function both in the early
postnatal period and later in life. To date, the causes of the glomerular
abnormalities in the preterm kidneys are unknown. Given that not all
preterm kidneys exhibit abnormal glomeruli, it is likely that it may be
factors in the intrauterine environment (that lead to preterm delivery)
that have adversely impacted upon the developing glomeruli or
alternatively, it may be factors in the extra-uterine environment
(haemodynamic and in the postnatal care) that have led to these
glomerular abnormalities (Figure 2). In addition, there may be
intrauterine factors and/or extra-uterine factors that adversely impact
on nephrogenesis without inflicting glomerular pathologies. In the
next sections, factors in the intrauterine environment (linked to the
induction of preterm birth) and in the extra-uterine environment that
could potentially adversely impact on the developing kidney are
discussed.
Figure 1: Representative photomicrograph of a preterm human
kidney, exhibiting an abnormal glomerulus with an enlarged
Bowman’s space and shrunken immature glomerular cells. These
abnormal glomeruli were only found in the outer renal cortex of
the preterm human kidney, suggesting that they were formed in the
extra-uterine environment. Scale bar 20 µm, stained with
Haematoxylin and Eosin.
Figure 2: Flow diagram showing the factors associated with the
etiology of premature delivery and factors in neonatal care that can
potentially adversely impact upon the developing kidney. This in
turn, can lead to impaired nephrogenesis and/or glomerular/
tubular injury in the preterm neonate, and subsequent reduction in
the number of functional nephrons at the beginning of life, leading
to long-term vulnerability to renal disease.
Factors that can Potentially Impact on the
Development of the Immature Kidney
Intrauterine factors
It is now well recognised that the in utero environment can directly
influence organ structure and development. Hence, it is likely that the
factors that lead to the induction of preterm delivery (spontaneous or
assisted) can potentially impact on nephrogenesis and/or render the
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kidneys vulnerable to premature delivery and subsequent pathology.
In the next sections we describe some of the common factors/
conditions associated with preterm birth and how these factors can
adversely impact on the development of the fetal kidney.
Intrauterine infection and inflammation (chorioamnionitis)
Intrauterine infection (in particular, chorioamnionitis) is widely
acknowledged as a major contributor to premature delivery [13,69],
especially in births prior to 32 weeks gestation [69,70]. A recent study
by Ogge et al. [71], found that chronic chorioamnionitis was involved
in 34% of the premature deliveries relating to preterm labour with
intact membranes and 39% of preterm labour with membrane rupture.
Chorioamnionitis is defined as inflammation of the chorion and
amnion, caused by a bacterial infection which typically ascends from
the vagina [3]. Importantly, chorioamnionitis can lead to fetal
inflammatory response syndrome (FIRS) [72], and this has been
shown to adversely influence neonatal organ development. The effect
of exposure to inflammation in utero on the fetal kidney has recently
been examined in fetal sheep [73,74]. In the study by Galinsky et al.
[73] , there was a 20% reduction in nephron number, without any
effect on body weight, when chorioamnionitis was induced in late
gestation, using an acute intra-amniotic bolus dose of
lipopolysaccharide (LPS, which initiates an inflammatory response
similar to that observed with chorioamnionitis). Interestingly,
however, when fetal lambs were exposed to a lower dose of LPS over a
chronic period, during the period in gestation when nephrogenesis is
rapidly ongoing, there were no observable detrimental effects on
nephrogenesis [74]. Hence, it appears that with chronic low dose
exposure that the kidney may be able to adapt, to prevent adverse
effects on nephron formation. The contrasting findings from these two
studiesdemonstrate that the timing, duration and extent of infection/
inflammation are important factors when assessing the impact of
chorioamnionitis on the developing kidney.
Maternal diabetes
Exposure to intrauterine maternal diabetes can significantly
influence fetal growth throughout gestation and lead to an early onset
to preterm birth; this is of concern given the recent rise in Type 1 and
type 2 and/or gestational diabetes [75,76]. A common consequence of
intrauterine exposure to maternal diabetes is macrosomia, in
particular asymmetric macrosomia [77]. Macrosomia oftenleads to
exaggerated fetal growth, whereby the baby is born with a birth weight
that is high for gestational age [78]. This increase in body weight is a
result of excessive amounts of glucose and other nutrients crossing the
placenta leading to an increase in fetal body growth. In contrast, when
maternal diabetes (both Type 1 and Type 2) is severe, this can lead to
IUGR in the infant [76,79]; the impacts of IUGR on the kidney are
described later. With the increased prevalence of maternal diabetes
there have been a number of recent studies looking at the effects on
the fetal kidney. In a study conducted in preterm and term babies born
to Pima Indian mother, exposure to maternal diabetes (Type 2
diabetes) during pregnancy led to a higher excretion of albumin (3.8
times higher) when compared to infants of pre-diabetic and non-
diabetic mothers; thus indicative of renal injury in offspring exposed
to diabetes in utero [80].
Animal studies, have reported an increased incidence of renal
malformations in offspring born to diabetic mothers (Type 1 diabetes)
[81,82]. In particular it has been shown that exposure to maternal
diabetes can adversely impact nephrogenesis, with the offspring of
diabetic mothers reported to have significantly smaller kidney and
glomerular size, accompanied with a 40% reduction in nephron
endowment [82]. The offspring of the diabetic mothers were
significantly smaller in body weight, but there was no difference in
kidney weight adjusted for body weight, compared to offspring of non-
diabetic mothers [82]. Of concern, exposure to diabetes in utero led to
greater glomerular and tubular apoptosis, compared to offspring not
exposed to diabetes with the level of hyperglycaemiaa strong
determinant of the severity of the adverse effects observed in the
kidneys [82].
It is important to note, that although many of the animal studies
relate to induction of type 1 diabetes in the mothers, the findings in
relation to fetal development are likely to be also relevant to maternal
type 2 and gestational diabetes, where the developing infant in all cases
of maternal diabetes is exposed to hyperglycemia.
Antenatal medications
In general, administration of medications during pregnancy is
avoided wherever possible, due to potential adverse effects on the
developing fetus. However, it is important to note that there are some
medications which are specifically administered to women ‘at risk’ of
delivering prematurely, and although these medications are
considered safe, they have the potential to adversely impact on the
developing fetal kidney. In this section, we describe what is currently
known in relation to these routinely prescribed medications.
Glucocorticoids
When it is considered likely that a woman will deliver prematurely,
she is routinely administered glucocorticoids, usually betamethasone
or dexamethasone. These medications have been shown to accelerate
the maturation of the fetal lungs and thus, enhance the survival of the
infant at preterm delivery [83,84]. In addition to the effects in the
newborn’s lungs, the administration of glucocorticoids has also been
observed to increase mean arterial blood pressure, renal blood flow
and glomerular filtration rate [85-87] this in turn, has the potential to
affect renal function.
The effect of glucocorticoids on the developing kidney has been
studied in animal models including: the rat [88-90], sheep [91-93] and
baboon [17,94]. The findings suggest that exposure to glucocorticoids
can affect nephron endowment and renal maturation. In sheep studies,
administration of glucocorticoids during pregnancy (over 26 -28 days
gestation) has been shown to significantly reduce nephron endowment
in the exposed offspring [95] and in the neonatal rat, a reduction in
glomerular density was observed when dexamethasone was
administered at a time of ongoing postnatal nephrogenesis [96]. In our
laboratory, we have looked at the effects of administration of antenatal
glucocorticoids in a preterm baboon model [17]. Encouragingly,
administration of antenatal glucocorticoids did not appear to have any
direct adverse effects on the developing kidney and nephron
endowment was within the normal range [17]. However, there was a
9% increase in developed glomeruli in the renal cortex in the
betamethasone-exposed neonates, and a reduction in the width of the
nephrogenic zone when compared to age-matched gestational
controls. This suggests that there is accelerated renal maturation in
response to glucocorticoid exposure and this is in accordance with
other studies that show accelerated organ maturation as a result of
glucocorticoid exposure [94,97].
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Antibiotics
Infants that deliver preterm are often pre-exposed to antibiotics in
utero, with antibiotics often prescribed to pregnant women with
chorioamnionitis. Importantly, in this regard, antibiotics such as the
aminoglycosides can readily cross the placenta [98] and there have
been a number of experimental studies linking antibiotics with
impairment of nephrogenesis [99-102]. For instance, it has been
shown that incubation of metanephroi in culture with gentamicin
leads to decreased branching morphogenesis of the ureteric tree and
thus reduced nephron formation [99]. In addition, administration of
antibiotics to guinea pig and rat dams has been shown to lead to
oligonephronia in the offspring [103].
Indomethacin
Another routinely administered medication to women ‘at risk’ of
preterm birth is indomethacin. Indomethacin is a tocolytic drug,
which functions to reduce prostaglandin synthesis; it is thereby highly
effective at prolonging pregnancy [104]. Of concern, however, in
rodent studies in utero exposure to indomethacin has been reported to
reduce nephron endowment and reduce glomerular filtration
[105,106].
Oligohydramnios
Oligohydramnios is characterised by reduced levels of amniotic
fluid during pregnancy. It can manifest as a result of fetal renal injury,
such as decreased renal blood flow and/or reduced renal perfusion,
which ultimately leads to a reduction in the amount of fetal urine
excretion and consequently, the amount of amniotic fluid [107]. Other
renal causes that attribute to a reduction in amniotic fluid include
congenital anomalies such as: renal agenesis, polycystic kidneys,
multicystic dysplastic kidneys and uteral or urtheral obstruction
rupture of membranes [108]. It is also suggested that oligohydramnios
can also result from bacterial infection within the amniotic cavity
(such as chorioamnionitis), causing redistribution of blood flow
within the developing fetus. A reduction in amniotic fluid at birth is
often indicative of renal insufficiency in the neonate [109]. In utero
detection of oligohydramnios often leads to the assisted induction of
preterm labour as oligohydramnios has been linked to a number of
inauspicious pregnancy outcomes such as perinatal death, fetal distress
labour, low birth weight and poor infant health at birth [110].
Intrauterine Growth Restriction (IUGR)
IUGR is defined as body growth below the 10th percentile for
gestational age. IUGR is multifactorial in origin with maternal race,
economic status, diet and lifestyle (which can be interlinked) and
complications of pregnancy all associated with induction of IUGR
(Figure 2). IUGR is often a co-morbidity of preterm birth and it is
linked both to spontaneous and assisted premature deliveries. In many
pregnancies, it is difficult to ascertain whether it is the underlying
cause of the IUGR, or the poor in utero growth of the fetus that is the
stimulus for spontaneous preterm delivery. Likewise, the developing
kidney can be directly impacted upon by the factors leading to IUGR,
or alternatively, it can be a direct corollary of the IUGR. Certainly, the
general consensus of the findings from the literature would support
the latter with IUGR (regardless of the underlying causes) linked to
poor organ development in the fetus and concomitant impairment of
kidney development [111,112]. In the next sections some of the
common factors associated with IUGR are described, including their
links with preterm delivery.
Maternal ethnicity/socio-economic status
Maternal race has been linked with premature delivery and IUGR
[3,113,114]. For example in the USA, African and African American
women have been shown to have a four times higher chance of
delivering a premature newborn compared to other racial groups [3].
In addition, women from South Asia and the Indian subcontinent
have very high rates of IUGR and low birth weight [3], whereas,
women from East Asia and Hispanic regions have been shown to have
lower rates of premature delivery. In Australia, Indigenous Australians
have a much higher frequency of IUGR and preterm delivery
(approximately twice that of non-indigenous Australians) [6,115]. It is
important to note, that in many of these populations (where there is a
high incidence of IUGR) there is also a low socioeconomic status.
Hence, the underlying cause of the IUGR may be due to poor maternal
nutrition, lifestyle insults and poor maternal health (all described
below), rather than their ethnicity per se.
Maternal diet
Malnutrition is a common cause of IUGR in underdeveloped
countries [116]. It can result by under nutrition (inadequate food
intake) and/or restriction of specific key nutrients in the diet. For
example, data from the Dutch famine during World War 2 found that
children born to mothers that had limited food available (less than
1000 calories per day) over the majority of their pregnancy gave birth
to babies that were small for gestational age [117]. In another large
study conducted in 538 women who delivered term, it was shown that
a reduced protein diet during pregnancy leads to low birth weight in
the neonate [118]. Similarly, in rat studies, IUGR is consistently
reported when rat dams are fed a low protein diet during pregnancy
[119-122].
Maternal lifestyle
Maternal behaviours such as smoking, high alcohol consumption,
and ingesting illicit drugs have all been recognised as contributors to
the risk of IUGR and premature birth [123-127]. Cigarette smoking
has been reported to increase the risk of premature rupture of the
membranes, pregnancy bleeding and pre-term labour. In addition,
maternal smoking has been identified as a major cause of IUGR in
developed countries, contributing to as high as 40% of all cases of
IUGR [116]. Smoking causes vascular changes in the mother that can
lead to placental insufficiency and hypoxia in the fetus [128]. It has
also been associated with the down-regulation of important miRNAs
of the placenta, leading to newborns that are small for gestational age
[128]. Furthermore, nicotine found in cigarettes has been shown to
pass the placenta, thus exerting a direct negative effect on the growth
of the fetus [128]. Importantly, Dejmek et al. [129] also showed that
reduced birth weight in newborns of smoking mothers was dose-
dependent (that is number of cigarettes smoked per day).
Consumption of alcohol and use of illicit drugs during pregnancy is
also linked to increased risk of preterm birth. In a cohort of 3000
African American women, alcohol and cocaine use was found to be
associated with extreme preterm birth [125]. Of particular concern, a
study by O’Leary et al. [127], found that moderate ingestion of alcohol
consumption (only during the first trimester of pregnancy) was
associated with pre-term birth In Australia, the high rate of preterm
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birth in the Indigenous community is thought to be attributed to high
rates of tobacco, alcohol and drug use in pregnant women [130].
Placental insufficiency/abruption
The placenta is a vital organ that develops specifically during
pregnancy to support the growth of the developing fetus. The role of
the placenta is to supply the fetus with an adequate amount of
nutrients and oxygen for normal fetal growth. In developed countries
the most common cause of IUGR is placental insufficiency [131,132]
and it is also strongly linked with preterm birth [133]. Placental
insufficiency occurs when the placenta does not develop normally and
thus it is unable to adequately support the developing baby. It is
usually caused by reduced uterine artery blood flow (uteroplacental
insufficiency) [131].
Placental abruption occurs in late gestation and is a serious
condition where the placenta partially, or completely, separates from
the lining of the uterus; the effects on the developing fetus depend on
the severity [134]. The full separation of the placenta from the uterus
lining can lead to in utero death and subsequent stillbirth, if the fetus
is not delivered at the time of abruption. When there is partial
placental separation the fetus is growth restricted and preterm birth
will often ensue (spontaneous or assisted).
Pre-eclampsia
Pre-eclampsia is pregnancy-associated hypertension [135]; it is a
multi-system disorder which affects approximately 8% of pregnancies
[136]. It occurs when placentation is abnormal, which can cause the
mother to experience intravascular coagulation, bleeding and organ
failure (hepatic and renal) following poor perfusion. These
complications subside with the delivery of the fetus. Severe pre-
eclampsia can lead to maternal death and thus, it is a major cause of
assisted preterm birth [137]. In addition, pre-eclampsia during
pregnancy is a major risk factor for IUGR [138,139] as it usually
results in placental insufficiency. Higher rates of pre-eclampsia are
seen amongst women with pre-existing hypertension, diabetes mellitus
or previous history of pre-eclampsia [140]. Of concern, there has been
an increased incidence of pre-eclampsia in developing countries over
recent years [141].
Multiple births
Pregnancies with multiple fetuses exhibit a higher risk of placental
dysfunction and placental insufficiency. This is associated with the
slowed growth rate of twins during late gestation when compared to
the singleton growth rate [142]. The incidence of multiple births is
increasing and this is largely attributed to the increase in availability of
infertility treatment, such as ovulation induction [143,144].
Monochorionic twins (identical twins that share one placenta) have a
much greater chance of being born IUGR than dichorionic twins
(twins that do not share the same placenta) [145,146]. Discordant
growth, results from unequal distribution of uteroplacental blood flow
to the fetuses [147].
IUGR adversely Impacts on Nephron Endowment at Birth
It is now well established that IUGR, regardless of the etiological
origins (many of these described above), can adversely impact on the
number of nephrons formed within the developing kidney. Indeed
there are many experimental studies that have shown that when IUGR
is induced by maternal dietary manipulations, or by induction of
placental insufficiency, that nephron number is reduced in the
offspring [148-152]. In general, nephron endowment at birth is
directly proportional to kidney size [17,153,154], so in the case of the
IUGR infant the reduction in body size at birth is accompanied by a
decrease in kidney size and in the number of nephrons. In support of
this concept, in autopsied human kidneys there was a linear
relationship between the number of glomeruli (and therefore
nephrons) and birth weight in full term neonates[155]; neonates below
the 10th percentile of birth weight had 30% fewer glomeruli than the
neonates with birth weights above the 10th percentile[155].
However, it is important to note that the timing of the growth insult
during gestation is important. If the growth restriction occurs late in
gestation, when nephrogenesis is already complete, or close to
completion, the number of nephrons formed within the kidney will
not be affected by the IUGR, yet birth weight will be significantly
reduced. For example, in a study performed in our laboratory [151],
placental insufficiency was experimentally induced in fetal lambs late
in gestation (from 120-140 days gestation; term is 147 days) at a time
when nephrogenesis was nearing completion. This study revealed a
significant decrease in body weight and kidney weight in response to
IUGR compared to appropriately grown lambs. However, nephron
endowment in the IUGR lambs was not different to the control lambs.
In contrast, IUGR caused by twinning led to a significant reduction in
nephron endowment [151].
Extra-uterine (Postnatal) factors
There are a number of factors in the postnatal environment
(haemodynamic and factors associated with postnatal care), that can
potentially adversely impact on the immature kidneys of the preterm
infant. Some of the major ones are described below.
Change in haemodynamics
There is a major hemodynamic transition at the time of birth, when
the circulatory dependence on the placenta is terminated and the in
utero configuration of circulation is changed to the ex utero
configuration [156]. In the immediate period following birth the
kidneys need to rapidly adapt to the extra-uterine environment
whereby they are now required to independently control fluid and
electrolyte levels [20]. Following birth, there is also a significant
increase in mean arterial pressure and cardiac output and a reduced
renal vascular resistance facilitates an increase in renal blood flow [33].
Since resistance of the afferent and efferent arterioles is a determinant
of glomerular capillary pressure the glomerular filtration rate also
increases at birth and sodium reabsorption subsequently increases
[157]. Hence, the immature kidneys of preterm infants are exposed to
a marked increase in renal blood flow and blood pressure in the
immediate neonatal period and this has the potential to lead to renal
injury. To date, there is little information as to how changes in renal
blood flow and pressure directly impact on nephrogenesis and on the
recently formed immature nephrons in the preterm kidney. It is
conceivable that increases in blood flow and blood pressure could lead
to renal vascular injury and to the glomerular injury observed in
preterm infants. In this regard, in future studies it will be important to
look at the role of renal endothelial function in relation to prematurity.
Certainly, endothelial dysfunction has been described in other organs
following preterm birth and IUGR. Low birth weight and premature
birth has been previously reported to cause endothelial dysfunction in
the intestines, skin, retinal vessels and peripheral arteries [158]. Hence,
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it is plausible to suggest that preterm birth and low birth weight could
also affect developing arteries and capillaries in the immature kidney.
It is imperative in future studies to address this.
Hyperoxia and ventilation
In utero, the fetus normally develops in a relatively hypoxic
environment (5% oxygen) and this facilitates both vascular and
tubular development in the kidney [159-161]. At birth, the neonate is
exposed to an abrupt increase in oxygen from ~5% to 21% [161]. The
blood oxygen saturation levels (SpO2) rise from 45-55% in the fetus
[162] to 80-90% in the first five minutes after birth [163]. Hence, when
a baby is born preterm, the immature kidney is no longer growing in
an hypoxic environment and hence, it is likely that this will lead to
deleterious effects on the growth of the renal vasculature and the
tubules. This is an important area for future research and to our
knowledge this has not been investigated.
In addition, in the preterm neonate the lungs are very immature at
the time of birth; therefore, the neonate requires resuscitation and
ongoing ventilation [164]. Exposure to supplemental oxygen therapies,
such as ventilation, can lead to exposure to very high concentrations of
O2 (up to 100%), in an attempt to normalise blood oxygen levels
[165,166]. However, during this process the infant can experience high
blood oxygen levels (often only transitory) until the blood oxygen
levels become normalised. Of concern, hyperoxia can lead to oxidative
stress of the neonate, which has been shown to subsequently cause
cellular injury and cell death in response to accumulation of free
radicals and thereby exhaustion of antioxidants[167,168].
Consequently, this can lead to a number of common morbidities of
prematurity such as, retinopathy of prematurity, necrotizing
enterocolitis and bronchopulmonary dysplasia [169]. In the kidney of
the human neonate, oxidative stress has been reported to cause tubular
injury [170] and it has been linked to impairment of nephrogenesis in
animal studies [171]. In the rat model (where nephrogenesis is
ongoing in the first two weeks after birth), a significant reduction of
nephrons (25%) was reported in adulthood (25-35 weeks of age) [171]
following exposure to 80% oxygen during the early postnatal period.
In contrast, however, in a more recent study [172], exposure to 65%
oxygen levels for seven days of postnatal life, did not appear to have
any deleterious effects on nephrogenesis. However, in that study, the
kidneys of the hyperoxia-exposed mice did exhibit glomerular
hypertrophy in adulthood (postnatal day 56), suggestive of possible
reduced renal functional capacity.
Neonatal medications
Preterm infants are administered many medications in the
immediate period following birth; the treatment regime varies from
infant to infant and is ultimately dependent on the clinical sequelae of
each infant. Many of the medications administered to the infants are
known to be toxic to the kidneys but their benefits to the infant
outweigh the potential adverse effects on the kidneys. Some of the
commonly administered drugs are: non-steroidal anti-inflammatory
drugs (NSAIDs) such as indomethacin and ibuprofen and
aminoglycoside antibiotics (such as gentamicin). There are a number
of experimental studies which demonstrate that treatment with these
medications can have adverse effects on renal function in the postnatal
period and lead to renal injury [173-176]
NSAIDS
In the preterm neonate, exposure to indomethacin after birth has
been shown to lead to a significant increase in the concentration of
podocytes in the urine, as well as increased urine albumin excretion
[177], suggestive of renal injury. Treatment with NSAIDs is also linked
to impaired renal function. A recent study of renal function in preterm
babies indicated that NSAIDs administered to the preterm infant
significantly reduced neonatal renal drug clearance, likely associated
with a reduced GFR [178]. In the rodent model, postnatal
administration of NSAIDs and/or gentamicin during the period of
postnatal nephrogenesis is associated with a number of structural
changes in immature rodent kidneys [102]. These changes include
proximal tubule vacuolization, interstitial oedema, and podocyte foot
process effacement; the most severe effects were observed in animals
that received combined NSAID and gentamicin treatment. In these
studies early administration of indomethacin caused a significant
reduction in nephron endowment at 14 days postnatal age in rats,
however, these effects were not observed in the kidney when exposed
to ibuprofen. In the mouse model, postnatal exposure to NSAIDs
caused a significant reduction in glomerular density and glomerular
and tubular volumes in the kidneys [179]. Importantly, in preterm
baboons (born at a time, equivalent to ~27 week gestation in the
human), administration of ibuprofen during the postnatal period
caused a significant reduction in nephrogenic zone width [180]. This
suggests that prostaglandin inhibition may result in the early cessation
of nephrogenesis.
Antibiotics
It is known that antibiotics, such as the aminoglycosides, can be
nephrotoxic in the newborn (with the preterm infant most vulnerable)
[101] and they are also linked with impairment of nephrogenesis
[103,173]. Administration of gentamicin in neonates has been shown
to primarily result in renal tubular necrosis [100], which consequently
leads to increased sodium excretion, proteinuria, and a significant
reduction in GFR [101,181,182].
Preterm infants are often exposed to antibiotics in utero (see earlier
section) and/or in the postnatal period when there is evidence of
infection. In this regard, in a study of preterm human infants, using a
multivariate logistic analysis, it was found that mothers of infants with
acute renal failure received more drugs during pregnancy and delivery
(mainly antibiotics and non-steroidal anti-inflammatory drugs) [183].
Moreover, in the first few days of life and before diagnosis of acute
renal failure, the preterm infants that developed renal failure received
more drugs (antibiotics, NSAIDs and diuretics) and for a longer
period [183].
Postnatal Nutrition
Recent studies highlight the importance of postnatal nutrition on
the growth and function of the kidney in IUGR and preterm infants.
Certainly, when nephrogenesis is ongoing there are usually strong
linear correlations between nephron number and kidney size [155].
Impaired growth after birth (extra-uterine growth restriction; EUGR)
often occurs during the postnatal period in preterm infants [181];
hence, it is likely that impaired body growth in the immediate period
after birth will adversely affect kidney growth and nephron
endowment in the preterm infant. Therefore, there is the potential for
improved postnatal nutrition to positively impact on the number of
nephrons formed. In support of this idea, in a recent study of preterm
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children (born <30 weeks gestation) [182] glomerular filtration rate
was significantly decreased (suggestive of reduced nephron
endowment) at 7 years of age, in those that were either intra or extra-
uterine growth restricted. Importantly, the extra-uterine growth
restricted children were found to have significantly lower protein-
energy intake during their first week of life when compared to IUGR
or appropriately grown children. In addition, Schmidt et al. [183]
observed that consuming protein-rich formula, compared to just
breast milk, during the early postnatal period caused a significant
increase in kidney size.
Conclusion
This review highlights the many factors associated with the etiology
of preterm birth and in the postnatal environment that can potentially
impact on the immature kidney of the preterm infant. In order to
improve long-term renal health in subjects born preterm, it is now
important in future studies, to develop interventional strategies that
mitigate the adverse impact of the intrauterine and extra-uterine
environment on the immature kidney. At this stage, there is no clear
indicator of the causes of the glomerular abnormalities associated with
preterm birth. Carefully controlled animal studies can help to
elucidate the causes of the glomerular abnormalities and this is an
important area of future research. In regards to renal injury, this
review highlights a number of medications, commonly used in the
neonatal intensive care unit that can lead to renal impairment. Hence,
it is the challenge for the neonatologist, when deciding to use these
medications, to ascertain whether the benefits outweigh the risks.
References
1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, et al.
(2012) National, regional, and worldwide estimates of preterm birth rates
in the year 2010 with time trends since 1990 for selected countries: a
systematic analysis and implications. Lancet 379: 2162-2172.
2. Tucker J, Mc Guire W (2004) Epidemiology of preterm birth. BMJ 329:
675-678.
3. Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology
and causes of preterm birth. Lancet 371: 75-84.
4. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, et al. (2010) The
worldwide incidence of preterm birth: a systematic review of maternal
mortality and morbidity. Bull World Health Organ 88: 31-38.
5. Mathews TJ, Miniño AM, Osterman MJ, Strobino DM, Guyer B (2011)
Annual summary of vital statistics: 2008. Pediatrics 127: 146-157.
6. Laws Pj, Li Z, Sullivan EA (2010) Australia’s mothers and babies 2008.
Perinatal statistics, Australian Institute of Health and Welfare, Australia.
7. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Kirmeyer S, et al.
(2011) Births: final data for 2009. Natl Vital Stat Rep 60: 1-70.
8. Allen MC, Donohue PK, Dusman AE (1993) The limit of viability--
neonatal outcome of infants born at 22 to 25 weeks' gestation. N Engl J
Med 329: 1597-1601.
9. Kutz P, Horsch S, Kühn L, Roll C (2009) Single-centre vs. population-
based outcome data of extremely preterm infants at the limits of viability.
Acta Paediatr 98: 1451-1455.
10. Roberts D, Dalziel S (2006) Antenatal corticosteroids for accelerating
fetal lung maturation for women at risk of preterm birth. Cochrane
Database Syst Rev : CD004454.
11. Pulver LS, Guest-Warnick G, Stoddard GJ, Byington CL, Young PC
(2009) Weight for gestational age affects the mortality of late preterm
infants. Pediatrics 123: e1072-1077.
12. Kallapur SG, Ikegami M (2006) Physiological consequences of
intrauterine insults. Paediatr Respir Rev 7: 110-116.
13. Goldenberg RL, Hauth JC, Andrews WW (2000) Intrauterine infection
and preterm delivery. N Engl J Med 342: 1500-1507.
14. De Felice C, Toti P, Laurini RN, Stumpo M, Picciolini E, et al. (2001)
Early neonatal brain injury in histologic chorioamnionitis. J Pediatr 138:
101-104.
15. Kafetzis DA, Skevaki C, Costalos C (2003) Neonatal necrotizing
enterocolitis: an overview. Curr Opin Infect Dis 16: 349-355.
16. Rodríguez MM, Gómez AH, Abitbol CL, Chandar JJ, Duara S, et al.
(2004) Histomorphometric analysis of postnatal glomerulogenesis in
extremely preterm infants. Pediatr Dev Pathol 7: 17-25.
17. Gubhaju L, Sutherland MR, Yoder BA, Zulli A, Bertram JF, et al. (2009)
Is nephrogenesis affected by preterm birth? Studies in a non-human
primate model. Am J Physiol Renal Physiol 297: 1668-1677.
18. Gubhaju L, Sutherland MR, Black MJ (2011) Preterm birth and the
kidney: implications for long-term renal health. Reprod Sci 18: 322-333.
19. Sutherland MR, Gubhaju L, Moore L, Kent AL, Dahlstrom JE, et al.
(2011) Accelerated maturation and abnormal morphology in the preterm
neonatal kidney. J Am Soc Nephrol 22: 1365-1374.
20. Aperia A, Broberger O, Elinder G, Herin P, Zetterström R (1981)
Postnatal development of renal function in pre-term and full-term
infants. Acta Paediatr Scand 70: 183-187.
21. Bueva A, Guignard JP (1994) Renal function in preterm neonates. Pediatr
Res 36: 572-577.
22. Arant BS Jr (1978) Developmental patterns of renal functional
maturation compared in the human neonate. J Pediatr 92: 705-712.
23. Satlin LM, Woda CB, Schwartz GJ: Development of function in the
metanephric kidney; in Vize PD, Woolf A, Bard JBL (eds): The kidney:
From normal development to congenital disease. Sydney, Academic
Press, 2003
24. Stapleton FB, Jones DP, Green RS (1987) Acute renal failure in neonates:
incidence, etiology and outcome. Pediatr Nephrol 1: 314-320.
25. Choker G, Gouyon JB (2004) Diagnosis of acute renal failure in very
preterm infants. Biol Neonate 86: 212-216.
26. Siegel SR, Oh W (1976) Renal function as a marker of human fetal
maturation. Acta Paediatr Scand 65: 481-485.
27. Finney H, Newman DJ, Thakkar H, Fell JM, Price CP (2000) Reference
ranges for plasma cystatin C and creatinine measurements in premature
infants, neonates, and older children. Arch Dis Child 82: 71-75.
28. Schreuder MF, Wilhelm AJ, Bökenkamp A, Timmermans SM,
Delemarre-van de Waal HA, et al. (2009) Impact of gestational age and
birth weight on amikacin clearance on day 1 of life. Clin J Am Soc
Nephrol 4: 1774-1778.
29. Clark PM, Bryant TN, Hall MA, Lowes JA, Rowe DJ (1989) Neonatal
renal function assessment. Arch Dis Child 64: 1264-1269.
30. Gordjani N, Burghard R, Leititis JU, Brandis M (1988) Serum creatinine
and creatinine clearance in healthy neonates and prematures during the
first 10 days of life. Eur J Pediatr 148: 143-145.
31. Iacobelli S, Bonsante F, Ferdinus C, Labenne M, Gouyon JB (2009)
Factors affecting postnatal changes in serum creatinine in preterm
infants with gestational age <32 weeks. J Perinatol 29: 232-236.
32. Ross B, Cowett RM, Oh W (1977) Renal functions of low birth weight
infants during the first two months of life. Pediatr Res 11: 1162-1164.
33. Fawer CL, Torrado A, Guignard JP (1979) Maturation of renal function
in full-term and premature neonates. Helv Paediatr Acta 34: 11-21.
34. Sulyok E, Varga F, Györy E, Jobst K, Csaba IF (1979) Postnatal
development of renal sodium handling in premature infants. J Pediatr 95:
787-792.
35. Wilkins BH (1992) Renal function in sick very low birthweight infants: 4.
Glucose excretion. Arch Dis Child 67: 1162-1165.
36. Gallini F, Maggio L, Romagnoli C, Marrocco G, Tortorolo G (2000)
Progression of renal function in preterm neonates with gestational age <
or = 32 weeks. Pediatr Nephrol. 15:119-124.
37. Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, et al. (2006)
Postnatal renal function in preterm newborns: a role of diseases, drugs
and therapeutic interventions. Pediatr Nephrol 21: 931-938.
Citation: Ryan D, Black MJ (2015) Preterm Birth and/or Factors that Lead to Preterm Delivery: Effects on the Neonatal Kidney. J Neonatal Biol 4:
168. doi:10.4172/2167-0897.1000168
Page 8 of 12
J Neonatal Biol
ISSN:2167-0897 JNB, an open access journal
Volume 4 • Issue 1 • 1000168
100
38. Thayyil S, Sheik S, Kempley ST, Sinha A (2008) A gestation- and
postnatal age-based reference chart for assessing renal function in
extremely premature infants. J Perinatol 28: 226-229.
39. Gubhaju L, Sutherland MR, Horne RS, Medhurst A, Kent AL, et al.
(2014) Assessment of renal functional maturation and injury in preterm
neonates during the first month of life. Am J Physiol Renal Physiol 307:
149-158.
40. Galaske RG (1986) Renal functional maturation: renal handling of
proteins by mature and immature newborns. Eur J Pediatr 145: 368-371.
41. Tsukahara H, Yoshimoto M, Saito M, Sakaguchi T, Mitsuyoshi I, et al.
(1990) Assessment of tubular function in neonates using urinary beta 2-
microglobulin. Pediatr Nephrol 4: 512-514.
42. Fell JM, Thakkar H, Newman DJ, Price CP (1997) Measurement of
albumin and low molecular weight proteins in the urine of newborn
infants using a cotton wool ball collection method. Acta Paediatr 86:
518-522.
43. Awad H, el-Safty I, el-Barbary M, Imam S (2002) Evaluation of renal
glomerular and tubular functional and structural integrity in neonates.
Am J Med Sci 324: 261-266.
44. Mathieson PW (2004) The cellular basis of albuminuria. Clin Sci (Lond)
107: 533-538.
45. Tomlinson PA (1992) Low molecular weight proteins in children with
renal disease. Pediatr Nephrol 6: 565-571.
46. Christensen EI, Birn H (2001) Megalin and cubilin: synergistic endocytic
receptors in renal proximal tubule. Am J Physiol Renal Physiol 280:
F562-573.
47. Tsukahara H, Fujii Y, Tsuchida S, Hiraoka M, Morikawa K, et al. (1994)
Renal handling of albumin and beta-2-microglobulin in neonates.
Nephron 68: 212-216.
48. Hentschel R, Lödige B, Bulla M (1996) Renal insufficiency in the neonatal
period. Clin Nephrol 46: 54-58.
49. Andreoli SP (2004) Acute renal failure in the newborn. Semin Perinatol
28: 112-123.
50. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute
renal failure - definition, outcome measures, animal models, fluid
therapy and information technology needs: The second international
consensus conference of the acute dialysis quality initiative (adqi) group.
Crit Care.8: R204-212.
51. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, et al. (2007)
Acute Kidney Injury Network: report of an initiative to improve
outcomes in acute kidney injury. Crit Care 11: R31.
52. Walker MW, Clark RH, Spitzer AR (2011) Elevation in plasma creatinine
and renal failure in premature neonates without major anomalies:
Terminology, occurrence and factors associated with increased risk. J
Perinatol. 31:199-205.
53. Cataldi L, Leone R, Moretti U, De Mitri B, Fanos V, et al. (2005) Potential
risk factors for the development of acute renal failure in preterm
newborn infants: a case-control study. Arch Dis Child Fetal Neonatal Ed
90: F514-519.
54. Keijzer-Veen M, Schrevel M, Finken M, Dekker F, Nauta J, et al. (2005)
Microalbuminuria and lower glomerular filtration rate at young adult age
in subjects born very premature and after intrauterine growth
retardation. Journal of the American Society of Nephrology 16:
2762-2768.
55. Rodríguez-Soriano J, Aguirre M, Oliveros R, Vallo A (2005) Long-term
renal follow-up of extremely low birth weight infants. Pediatr Nephrol
20: 579-584.
56. Iacobelli S, Loprieno S, Bonsante F, Latorre G, Esposito L, et al. (2007)
Renal function in early childhood in very low birthweight infants. Am J
Perinatol 24: 587-592.
57. Rodriguez MM, Gomez A, Abitbol C, Chandar J, Montané B, et al. (2005)
Comparative renal histomorphometry: a case study of oligonephropathy
of prematurity. Pediatr Nephrol 20: 945-949.
58. Siewert-Delle A, Ljungman S (1998) The impact of birth weight and
gestational age on blood pressure in adult life: a population-based study
of 49-year-old men. Am J Hypertens 11: 946-953.
59. Irving RJ, Belton NR, Elton RA, Walker BR (2000) Adult cardiovascular
risk factors in premature babies. Lancet 355: 2135-2136.
60. Kistner A, Celsi G, Vanpee M, Jacobson SH (2000) Increased blood
pressure but normal renal function in adult women born preterm.
Pediatr Nephrol 15: 215-220.
61. Bonamy AK, Bendito A, Martin H, Andolf E, Sedin G, et al. (2005)
Preterm birth contributes to increased vascular resistance and higher
blood pressure in adolescent girls. Pediatr Res 58: 845-849.
62. Bonamy AK, Martin H, Jörneskog G, Norman M (2007) Lower skin
capillary density, normal endothelial function and higher blood pressure
in children born preterm. J Intern Med 262: 635-642.
63. Cooper R, Atherton K, Power C (2009) Gestational age and risk factors
for cardiovascular disease: evidence from the 1958 British birth cohort
followed to mid-life. Int J Epidemiol 38: 235-244.
64. Ciccone MM, Scicchitano P, Zito A, Gesualdo M, Sassara M, et al. (2011)
Different functional cardiac characteristics observed in term/preterm
neonates by echocardiography and tissue doppler imaging. Early Hum
Dev.87:555-558.
65. Mercuro G, Bassareo PP, Flore G, Fanos V, Dentamaro I, et al. (2013)
Prematurity and low weight at birth as new conditions predisposing to an
increased cardiovascular risk. Eur J Prev Cardiol 20: 357-367.
66. Brenner BM, Chertow GM (1994) Congenital oligonephropathy and the
etiology of adult hypertension and progressive renal injury. Am J Kidney
Dis 23: 171-175.
67. Hinchliffe SA, Sargent PH, Howard CV, Chan YF, Van Velzen D (1991)
Human intrauterine renal growth expressed in absolute number of
glomeruli assessed by the disector method and cavalieri principle. Lab
Invest 64: 777-784.
68. Faa G, Gerosa C, Fanni D, Nemolato S, Locci A, et al. (2010) Marked
interindividual variability in renal maturation of preterm infants: lessons
from autopsy. J Matern Fetal Neonatal Med 23 Suppl 3: 129-133.
69. Mueller-Heubach E, Rubinstein DN, Schwarz SS (1990) Histologic
chorioamnionitis and preterm delivery in different patient populations.
Obstet Gynecol 75: 622-626.
70. Lahra MM, Jeffery HE (2004) A fetal response to chorioamnionitis is
associated with early survival after preterm birth. Am J Obstet Gynecol
190: 147-151.
71. Oggé G, Romero R, Lee DC, Gotsch F, Than NG, et al. (2011) Chronic
chorioamnionitis displays distinct alterations of the amniotic fluid
proteome. J Pathol 223: 553-565.
72. Gantert M, Been JV, Gavilanes AW, Garnier Y, Zimmermann LJ, et al.
(2010) Chorioamnionitis: a multiorgan disease of the fetus? J Perinatol 30
Suppl: S21-30.
73. Galinsky R, Moss TJ, Gubhaju L, Hooper SB, Black MJ, et al. (2011)
Effect of intra-amniotic lipopolysaccharide on nephron number in
preterm fetal sheep. Am J Physiol Renal Physiol 301: F280-285.
74. Ryan D, Atik A, De Matteo R, Harding R, Black MJ (2013) Chronic
intrauterine exposure to endotoxin does not alter fetal nephron number
or glomerular size. Clin Exp Pharmacol Physiol.
75. Hunt KJ, Schuller KL (2007) The increasing prevalence of diabetes in
pregnancy. Obstet Gynecol Clin North Am 34: 173-199, vii.
76. Magon N, Chauhan M (2012) Pregnancy in Type 1 Diabetes Mellitus:
How Special are Special Issues? N Am J Med Sci 4: 250-256.
77. Aerts L, Holemans K, Van Assche FA (1990) Maternal diabetes during
pregnancy: consequences for the offspring. Diabetes Metab Rev 6:
147-167.
78. Jovanovic L (2001) What is so bad about a big baby? Diabetes Care 24:
1317-1318.
79. Rowan JA, Luen S, Hughes RC, Sadler LC, McCowan LM (2009)
Customised birthweight centiles are useful for identifying small-for-
gestational-age babies in women with type 2 diabetes. Aust N Z J Obstet
Gynaecol 49: 180-184.
Citation: Ryan D, Black MJ (2015) Preterm Birth and/or Factors that Lead to Preterm Delivery: Effects on the Neonatal Kidney. J Neonatal Biol 4:
168. doi:10.4172/2167-0897.1000168
Page 9 of 12
J Neonatal Biol
ISSN:2167-0897 JNB, an open access journal
Volume 4 • Issue 1 • 1000168
101
80. Nelson RG, Morgenstern H, Bennett PH (1998) Intrauterine diabetes
exposure and the risk of renal disease in diabetic Pima Indians. Diabetes
47: 1489-1493.
81. Zhang SL, Chen YW, Tran S, Chenier I, Hébert MJ, et al. (2007) Reactive
oxygen species in the presence of high glucose alter ureteric bud
morphogenesis. J Am Soc Nephrol 18: 2105-2115.
82. Tran S, Chen YW, Chenier I, Chan JS, Quaggin S, et al. (2008) Maternal
diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol
19: 943-952.
83. Shanks A, Gross G, Shim T, Allsworth J, Sadovsky Y, et al. (2010)
Administration of steroids after 34 weeks of gestation enhances fetal lung
maturity profiles. Am J Obstet Gynecol 203: 47.
84. Crowther CA, McKinlay CJ, Middleton P, Harding JE (2011) Repeat
doses of prenatal corticosteroids for women at risk of preterm birth for
improving neonatal health outcomes. Cochrane Database Syst Rev:
CD003935.
85. al-Dahan J, Stimmler L, Chantler C, Haycock GB (1987) The effect of
antenatal dexamethasone administration on glomerular filtration rate
and renal sodium excretion in premature infants. Pediatr Nephrol.
1:131-135.
86. Kari M, Hallma M, Eronen M, Teramo K, Virtanen M, et al. (1994)
Prenatal dexamethasone treatment in conjunction with rescue therapy of
human surfactant: A randomized placebo-controlled multicenter study.
Pediatrics 93:730-736.
87. van den Anker JN, Hop WC, de Groot R, van der Heijden BJ, Broerse
HM, et al. (1994) Effects of prenatal exposure to betamethasone and
indomethacin on the glomerular filtration rate in the preterm infant.
Pediatr Res 36: 578-581.
88. Celsi G, Kistner A, Aizman R, Eklöf AC, Ceccatelli S, et al. (1998)
Prenatal dexamethasone causes oligonephronia, sodium retention, and
higher blood pressure in the offspring. Pediatr Res 44: 317-322.
89. Ortiz LA, Quan A, Weinberg A, Baum M (2001) Effect of prenatal
dexamethasone on rat renal development. Kidney Int 59: 1663-1669.
90. Ortiz LA, Quan A, Zarzar F, Weinberg A, Baum M (2003) Prenatal
dexamethasone programs hypertension and renal injury in the rat.
Hypertension 41: 328-334.
91. Stonestreet BS, Hansen NB, Laptook AR, Oh W (1983) Glucocorticoid
accelerates renal functional maturation in fetal lambs. Early Hum Dev 8:
331-341.
92. Ervin MG, Berry LM, Ikegami M, Jobe AH, Padbury JF, et al. (1996)
Single dose fetal betamethasone administration stabilizes postnatal
glomerular filtration rate and alters endocrine function in premature
lambs. Pediatr Res 40: 645-651.
93. Wintour EM, Moritz KM, Johnson K, Ricardo S, Samuel CS, et al. (2003)
Reduced nephron number in adult sheep, hypertensive as a result of
prenatal glucocorticoid treatment. J Physiol 549: 929-935.
94. Ervin MG, Seidner SR, Leland MM, Ikegami M, Jobe AH (1998) Direct
fetal glucocorticoid treatment alters postnatal adaptation in premature
newborn baboons. Am J Physiol 274: R1169-1176.
95. Moritz KM, De Matteo R, Dodic M, Jefferies AJ, Arena D, et al. (2011)
Prenatal glucocorticoid exposure in the sheep alters renal development in
utero: Implications for adult renal function and blood pressure control.
Am J Physiol Regul Integr Comp Physiol 301: R500-509.
96. de Vries WB, van den Borne P, Goldschmeding R, de Weger RA, Bal MP,
et al. (2010) Neonatal dexamethasone treatment in the rat leads to kidney
damage in adulthood. Pediatr Res 67: 72-76.
97. Jahnukainen T, Chen M, Berg U, Celsi G (2001) Antenatal
glucocorticoids and renal function after birth. Semin Neonatol 6:
351-355.
98. Pacifici GM (2006) Placental transfer of antibiotics administered to the
mother: a review. Int J Clin Pharmacol Ther 44: 57-63.
99. Gilbert T, Cibert C, Moreau E, Géraud G, Merlet-Bénichou C (1996)
Early defect in branching morphogenesis of the ureteric bud in induced
nephron deficit. Kidney Int 50: 783-795.
100. Rodriguez-Barbero A, López-Novoa JM, Arévalo M (1997) Involvement
of platelet-activating factor in gentamicin nephrotoxicity in rats. Exp
Nephrol 5: 47-54.
101. Giapros VI, Andronikou SK, Cholevas VI, Papadopoulou ZL (2003)
Renal function and effect of aminoglycoside therapy during the first ten
days of life. Pediatr Nephrol 18: 46-52.
102. Kent AL, Maxwell LE, Koina ME, Falk MC, Willenborg D, et al. (2007)
Renal glomeruli and tubular injury following indomethacin, ibuprofen,
and gentamicin exposure in a neonatal rat model. Pediatr Res 62:
307-312.
103. Gilbert T, Lelievre-Pegorier M, Merlet-Benichou C (1990) Immediate
and long-term renal effects of fetal exposure to gentamicin. Pediatr
Nephrol 4: 445-450.
104. Kurki T, Eronen M, Lumme R, Ylikorkala O (1991) A randomized
double-dummy comparison between indomethacin and nylidrin in
threatened preterm labor. Obstet Gynecol 78: 1093-1097.
105. Pomeranz A, Korzets Z, Dolfin Z, Eliakim A, Bernheim J, et al. (1996)
Acute renal failure in the neonate induced by the administration of
indomethacin as a tocolytic agent. Nephrol Dial Transplant 11:
1139-1141.
106. Kent AL, Douglas-Denton R, Shadbolt B, Dahlstrom JE, Maxwell LE, et
al. (2009) Indomethacin, ibuprofen and gentamicin administered during
late stages of glomerulogenesis do not reduce glomerular number at 14
days of age in the neonatal rat. Pediatric Nephrology 24: 1143-1149.
107. Vanderheyden T, Kumar S, Fisk NM (2003) Fetal renal impairment.
Semin Neonatol 8: 279-289.
108. Nyberg DA, Mc Gahan JP, Pretorius DH, Pilu G (2002) Diagnostic
imaging of fetal anomalies. Lippincott Williams & Wilkins, Philadelphia.
109. Klaassen I, Neuhaus TJ, Mueller-Wiefel DE, Kemper MJ (2007)
Antenatal oligohydramnios of renal origin: long-term outcome. Nephrol
Dial Transplant 22: 432-439.
110. Casey BM, McIntire DD, Bloom SL, Lucas MJ, Santos R, et al. (2000)
Pregnancy outcomes after antepartum diagnosis of oligohydramnios at
or beyond 34 weeks' gestation. Am J Obstet Gynecol 182: 909-912.
111. Hinchliffe SA, Lynch MR, Sargent PH, Howard CV, Van Velzen D
(1992) The effect of intrauterine growth retardation on the development
of renal nephrons. Br J Obstet Gynaecol 99: 296-301.
112. Mañalich R, Reyes L, Herrera M, Melendi C, Fundora I (2000)
Relationship between weight at birth and the number and size of renal
glomeruli in humans: a histomorphometric study. Kidney Int 58:
770-773.
113. Fiscella K1 (1996) Racial disparities in preterm births. The role of
urogenital infections. Public Health Rep 111: 104-113.
114. Schieve LA, Handler A (1996) Preterm delivery and perinatal death
among black and white infants in a Chicago-area perinatal registry.
Obstet Gynecol 88: 356-363.
115. de Onis M, Blössner M, Villar J (1998) Levels and patterns of intrauterine
growth retardation in developing countries. Eur J Clin Nutr 52 Suppl 1:
S5-15.
116. Painter RC, Roseboom TJ, Bleker OP (2005) Prenatal exposure to the
Dutch famine and disease in later life: an overview. Reprod Toxicol 20:
345-352.
117. Godfrey K, Robinson S, Barker DJ, Osmond C, Cox V (1996) Maternal
nutrition in early and late pregnancy in relation to placental and fetal
growth. BMJ 312: 410-414.
118. Langley SC, Jackson AA (1994) Increased systolic blood pressure in adult
rats induced by fetal exposure to maternal low protein diets. Clin Sci
(Lond) 86: 217-222.
119. Merlet-Bénichou C, Gilbert T, Muffat-Joly M, Lelièvre-Pégorier M, Leroy
B (1994) Intrauterine growth retardation leads to a permanent nephron
deficit in the rat. Pediatr Nephrol 8: 175-180.
120. Desai M, Crowther NJ, Lucas A, Hales CN (1996) Organ-selective growth
in the offspring of protein-restricted mothers. Br J Nutr 76: 591-603.
121. Zimanyi MA, Denton KM, Forbes JM, Thallas-Bonke V, Thomas MC, et
al. (2006) A developmental nephron deficit in rats is associated with
Citation: Ryan D, Black MJ (2015) Preterm Birth and/or Factors that Lead to Preterm Delivery: Effects on the Neonatal Kidney. J Neonatal Biol 4:
168. doi:10.4172/2167-0897.1000168
Page 10 of 12
J Neonatal Biol
ISSN:2167-0897 JNB, an open access journal
Volume 4 • Issue 1 • 1000168
102
increased susceptibility to a secondary renal injury due to advanced
glycation end-products. Diabetologia 49: 801-810.
122. Lazzaroni F, Bonassi S, Magnani M, Calvi A, Repetto E, et al. (1993)
Moderate maternal drinking and outcome of pregnancy. Eur J Epidemiol
9: 599-606.
123. Burguet A, Kaminski M, Abraham-Lerat L, Schaal JP, Cambonie G, et al.
(2004) The complex relationship between smoking in pregnancy and
very preterm delivery. Results of the Epipage study. BJOG 111: 258-265.
124. Sokol RJ, Janisse JJ, Louis JM, Bailey BN, Ager J, et al. (2007) Extreme
prematurity: an alcohol-related birth effect. Alcohol Clin Exp Res 31:
1031-1037.
125. Jaddoe VW, de Ridder MA, van den Elzen AP, Hofman A, Uiterwaal CS,
et al. (2008) Maternal smoking in pregnancy is associated with
cholesterol development in the offspring: A 27-years follow-up study.
Atherosclerosis 196: 42-48.
126. O'Leary CM, Nassar N, Kurinczuk JJ, Bower C (2009) The effect of
maternal alcohol consumption on fetal growth and preterm birth. BJOG
116: 390-400.
127. Maccani MA, Avissar-Whiting M, Banister CE, McGonnigal B, Padbury
JF, et al. (2010) Maternal cigarette smoking during pregnancy is
associated with downregulation of miR-16, miR-, and miR-146a in the
placenta. Epigenetics 5: 583-589.
128. Dejmek J, Solansk y I, Podrazilova K, Sram RJ (2002) The exposure of
nonsmoking and smoking mothers to environmental tobacco smoke
during different gestational phases and fetal growth. Environ Health
Perspect.110:601-606.
129. Henriksen T, Clausen T (2002) The fetal origins hypothesis: placental
insufficiency and inheritance versus maternal malnutrition in well-
nourished populations. Acta Obstet Gynecol Scand 81: 112-114.
130. Schreuder M, Delemarre-van de Waal H, van Wijk A (2006)
Consequences of intrauterine growth restriction for the kidney. Kidney
Blood Press Res 29: 108-125.
131. Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, et al. (2007)
Predictors of neonatal outcome in early-onset placental dysfunction.
Obstet Gynecol 109: 253-261.
132. Ananth CV, Smulian JC, Srinivas N, Getahun D, Salihu HM (2005) Risk
of infant mortality among twins in relation to placental abruption:
contributions of preterm birth and restricted fetal growth. Twin Res
Hum Genet 8: 524-531.
133. Lyell DJ, Lambert-Messerlian GM, Giudice LC (2003) Prenatal screening,
epidemiology, diagnosis, and management of preeclampsia. Clin Lab
Med 23: 413-442.
134. Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin
Perinatol 33: 130-137.
135. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365:
785-799.
136. Churchill D, Perry IJ, Beevers DG (1997) Ambulatory blood pressure in
pregnancy and fetal growth. Lancet 349: 7-10.
137. Walker BR, McConnachie A, Noon JP, Webb DJ, Watt GC (1998)
Contribution of parental blood pressures to association between low
birth weight and adult high blood pressure: cross sectional study. BMJ
316: 834-837.
138. Sibai BM (2003) Diagnosis and management of gestational hypertension
and preeclampsia. Obstet Gynecol 102: 181-192.
139. López-Jaramillo P, García RG, López M (2005) Preventing pregnancy-
induced hypertension: are there regional differences for this global
problem? J Hypertens 23: 1121-1129.
140. Smith AP, Ong S, Smith NC, Campbell D (2001) A prospective
longitudinal study of growth velocity in twin pregnancy. Ultrasound
Obstet Gynecol 18: 485-487.
141. Keith L, Oleszczuk JJ (1999) Iatrogenic multiple birth, multiple
pregnancy and assisted reproductive technologies. Int J Gynaecol Obstet
64: 11-25.
142. Fauser BC, Devroey P, Macklon NS (2005) Multiple birth resulting from
ovarian stimulation for subfertility treatment. Lancet 365: 1807-1816.
143. Lynch A, McDuffie R, Stephens J, Murphy J, Faber K, et al. (2003) The
contribution of assisted conception, chorionicity and other risk factors to
very low birthweight in a twin cohort. BJOG 110: 405-410.
144. Chang YL, Chang SD, Chao AS, Wang CN, Wang TH, et al. (2011) The
relationships of umbilical venous volume flow, birthweight and placental
share in monochorionic twin pregnancies with and without selective
intrauterine growth restriction. Twin Res Hum Genet 14: 192-197.
145. Breathnach FM, Malone FD (2012) Fetal growth disorders in twin
gestations. Semin Perinatol 36: 175-181.
146. Lucas SR, Costa Silva VL, Miraglia SM, Zaladek Gil F (1997) Functional
and morphometric evaluation of offspring kidney after intrauterine
undernutrition. Pediatr Nephrol 11: 719-723.
147. Louey S, Cock ML, Stevenson KM, Harding R (2000) Placental
insufficiency and fetal growth restriction lead to postnatal hypotension
and altered postnatal growth in sheep. Pediatr Res 48: 808-814.
148. Ozaki T, Nishina H, Hanson MA, Poston L (2001) Dietary restriction in
pregnant rats causes gender-related hypertension and vascular
dysfunction in offspring. J Physiol 530: 141-152.
149. Mitchell EK, Louey S, Cock ML, Harding R, Black MJ (2004) Nephron
endowment and filtration surface area in the kidney after growth
restriction of fetal sheep. Pediatr Res 55: 769-773.
150. Moritz KM, Mazzuca MQ, Siebel AL, Mibus A, Arena D, et al. (2009)
Uteroplacental insufficiency causes a nephron deficit, modest renal
insufficiency but no hypertension with ageing in female rats. J Physiol
587: 2635-2646.
151. Zohdi V, Moritz KM, Bubb KJ, Cock ML, Wreford N, et al. (2007)
Nephrogenesis and the renal renin-angiotensin system in fetal sheep:
effects of intrauterine growth restriction during late gestation. Am J
Physiol Regul Integr Comp Physiol 293: R1267-1273.
152. Sutherland MR, Gubhaju L, Yoder BA, Stahlman MT, Black MJ (2009)
The effects of postnatal retinoic acid administration on nephron
endowment in the preterm baboon kidney. Pediatr Res 65: 397-402.
153. Holland P (1993) Placental insufficiency and its effect on the fetus and
adult disease. Lancet 341: 827.
154. Veille JC, McNeil S, Hanson R, Smith N (1998) Renal Hemodynamics:
Longitudinal Study from the Late Fetal Life to One Year of Age J Matern
Fetal Investig 8: 6-10.
155. Arant BS Jr (1987) Postnatal development of renal function during the
first year of life. Pediatr Nephrol 1: 308-313.
156. Tulassay T, Vásárhelyi B (2002) Birth weight and renal function. Curr
Opin Nephrol Hypertens 11: 347-352.
157. Rodesch F, Simon P, Donner C, Jauniaux E (1992) Oxygen
measurements in endometrial and trophoblastic tissues during early
pregnancy. Obstet Gynecol 80: 283-285.
158. Fischer B, Bavister BD (1993) Oxygen tension in the oviduct and uterus
of rhesus monkeys, hamsters and rabbits. J Reprod Fertil 99: 673-679.
159. Tufro-McReddie A, Norwood VF, Aylor KW, Botkin SJ, Carey RM, et al.
(1997) Oxygen regulates vascular endothelial growth factor-mediated
vasculogenesis and tubulogenesis. Dev Biol 183: 139-149.
160. Finer N, Saugstad O, Vento M, Barrington K, Davis P, et al. (2010) Use of
oxygen for resuscitation of the extremely low birth weight infant.
Pediatrics 125: 389-391.
161. Kamlin CO, O'Donnell CP, Davis PG, Morley CJ (2006) Oxygen
saturation in healthy infants immediately after birth. J Pediatr 148:
585-589.
162. AHA, AAP (2006) 2005 American heart association (aha) guidelines for
cardiopulmonary resuscitation (cpr) and emergency cardiovascular care
(ecc) of pediatric and neonatal patients: Neonatal resuscitation
guidelines. Pediatrics 117: e1029-1038.
163. Tan A, Schulze A, O'Donnell CP, Davis PG (2005) Air versus oxygen for
resuscitation of infants at birth. Cochrane Database Syst Rev 18:
CD002273.
164. Rabi Y, Singhal N, Nettel-Aguirre A (2011) Room-air versus oxygen
administration for resuscitation of preterm infants: the ROAR study.
Pediatrics 128: e374-381.
Citation: Ryan D, Black MJ (2015) Preterm Birth and/or Factors that Lead to Preterm Delivery: Effects on the Neonatal Kidney. J Neonatal Biol 4:
168. doi:10.4172/2167-0897.1000168
Page 11 of 12
J Neonatal Biol
ISSN:2167-0897 JNB, an open access journal
Volume 4 • Issue 1 • 1000168
103
165. Vento M, Asensi M, Sastre J, Lloret A, García-Sala F, et al. (2003)
Oxidative stress in asphyxiated term infants resuscitated with 100%
oxygen. J Pediatr 142: 240-246.
166. Winterbourn CC (2008) Reconciling the chemistry and biology of
reactive oxygen species. Nat Chem Biol 4: 278-286.
167. Saugstad OD (2001) Update on oxygen radical disease in neonatology.
Curr Opin Obstet Gynecol 13: 147-153.
168. Perrone S, Mussap M, Longini M, Fanos V, Bellieni CV, et al. (2007)
Oxidative kidney damage in preterm newborns during perinatal period.
Clin Biochem 40: 656-660.
169. Yzydorczyk C, Comte B, Cambonie G, Lavoie JC, Germain N, et al.
(2008) Neonatal oxygen exposure in rats leads to cardiovascular and
renal alterations in adulthood. Hypertension 52: 889-895.
170. Sutherland MR, O'Reilly M, Kenna K, Ong K, Harding R, et al. (2013)
Neonatal hyperoxia: effects on nephrogenesis and long-term glomerular
structure. Am J Physiol Renal Physiol 304: F1308-1316.
171. Gilbert T, Gaonach S, Moreau E, Merlet-Benichou C (1994) Defect of
nephrogenesis induced by gentamicin in rat metanephric organ culture.
Lab Invest 70: 656-666.
172. Nathanson S, Moreau E, Merlet-Benichou C, Gilbert T (2000) In utero
and in vitro exposure to beta-lactams impair kidney development in the
rat. J Am Soc Nephrol 11: 874-884.
173. Cullen L, Young R, Bertram J (2000) Studies on the effects of gentamicin
on rat metanephric development in vitro. Nephrology. 5: 115-123.
174. Nagai J, Takano M (2004) Molecular aspects of renal handling of
aminoglycosides and strategies for preventing the nephrotoxicity. Drug
Metab Pharmacokinet 19: 159-170.
175. Kent AL, Brown L, Broom M, Broomfield A, Dahlstrom JE (2012)
Increased urinary podocytes following indomethacin suggests drug-
induced glomerular injury. Pediatr Nephrol 27: 1111-1117.
176. Allegaert K (2009) The impact of ibuprofen or indomethacin on renal
drug clearance in neonates. J Matern Fetal Neonatal Med 22 Suppl 3:
88-91.
177. Olliges A, Wimmer S, Nüsing RM (2011) Defects in mouse
nephrogenesis induced by selective and non-selective cyclooxygenase-2
inhibitors. Br J Pharmacol 163: 927-936.
178. Sutherland MR, Yoder BA, McCurnin D, Seidner S, Gubhaju L, et al.
(2012) Effects of ibuprofen treatment on the developing preterm baboon
kidney. Am J Physiol Renal Physiol 302: F1286-1292.
179. Langhendries JP, Battisti O, Bertrand JM (1988) Aminoglycoside
nephrotoxicity and urinary excretion of N-acetyl-beta-D-
glucosaminidase. Biol Neonate 53: 253-259.
180. Tugay S, Bircan Z, CaÄŸlayan C, Arisoy AE, Gkalp AS (2006) Acute
effects of gentamicin on glomerular and tubular functions in preterm
neonates. Pediatr Nephrol 21: 1389-1392.
181. Clark RH, Thomas P, Peabody J (2003) Extrauterine growth restriction
remains a serious problem in prematurely born neonates. Pediatrics 111:
986-990.
182. Bacchetta J, Harambat J, Dubourg L, Guy B, Liutkus A, et al. (2009) Both
extrauterine and intrauterine growth restriction impair renal function in
children born very preterm. Kidney Int 76: 445-452.
183. Schmidt IM, Damgaard IN, Boisen KA, Mau C, Chellakooty M, et al.
(2004) Increased kidney growth in formula-fed versus breast-fed healthy
infants. Pediatr Nephrol 19: 1137-1144.
Citation: Ryan D, Black MJ (2015) Preterm Birth and/or Factors that Lead to Preterm Delivery: Effects on the Neonatal Kidney. J Neonatal Biol 4:
168. doi:10.4172/2167-0897.1000168
Page 12 of 12
J Neonatal Biol
ISSN:2167-0897 JNB, an open access journal
Volume 4 • Issue 1 • 1000168
104
View publication stats
